Dr. Winters is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13123 E 16th Ave
# B115
Aurora, CO 80045Phone+1 720-777-6740
Education & Training
Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 2011 - 2014
Tulane University School of MedicineClass of 2011
Certifications & Licensure
CO State Medical License 2014 - 2025
OH State Medical License 2011 - 2014- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Publications & Presentations
PubMed
- 61 citationsThe STAT3-MYC Axis Promotes Survival of Leukemia Stem Cells by Regulating SLC1A5 and Oxidative Phosphorylation.Maria L. Amaya, Anagha Inguva, Shanshan Pei, Courtney L. Jones, Anna Krug
Blood. 2021-09-15 - 147 citationsFatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cellsBrett M. Stevens, Courtney L. Jones, Daniel A. Pollyea, Rachel Culp-Hill, Angelo D'Alessandro
Nature Cancer. 2020-10-26 - 18 citationsA Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.Shanshan Pei, Ian T Shelton, Austin E Gillen, Brett M Stevens, Maura Gasparetto
Cancer Discovery. 2023-09-06
Abstracts/Posters
- Outcomes Following Allogeneic Stem Cell Transplantation for AML in First Completion Remission Are Comparable between MRD Negative Patients and MRD Positive Patients Re...Amanda Winters, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Tracking of AML-Associated Mutations Via Droplet Digital PCR Is Predictive of Outcomes Post-Transplant2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- WT1 and BCORL1 Identified By Computational Biology Modeling Analysis of Patient Genomics Are Novel Predictors of Response to Azacitidine (AZA) and Lenalidomide (LEN) T...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Can One Blood Test Transform Cancer Screening?March 20th, 2023
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
